MedTrace Logo

Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions

NCT02308787 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2016-06-15

Study results available
· View outcomes & findings →

Summary

Multicenter, Retrospective Data Collection of Routine Clinical Use with the Spectra Optia® Apheresis System for Platelet Depletion Procedures.

Conditions

  • Thrombocythemia
  • Myeloproliferative Disease
  • Thrombocytosis

Interventions

DEVICE

Spectra Optia Apheresis System

Platelet Depletion

Sponsors & Collaborators

  • Terumo BCT

    lead INDUSTRY

Principal Investigators

  • Raymond P Goodrich, PhD · VP, Scientific and Clinical Affairs; Chief Science Officer-BBT

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Denmark
  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02308787 on ClinicalTrials.gov